Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""INDUCTION"" wg kryterium: Temat


Tytuł :
Exploring the determinants that influence hospital costs of induction therapy for acute myeloid leukemia.
Autorzy :
Ning L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lu P; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Que Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 May; Vol. 62 (5), pp. 1211-1218. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Induction Chemotherapy*
Leukemia, Myeloid, Acute*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Hospital Costs ; Hospitals ; Humans ; Remission Induction ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203.
Autorzy :
Moseley A; Public Health Sciences Division and SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Othus M; Public Health Sciences Division and SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Erba HP; Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1774-1777. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural
MeSH Terms :
Induction Chemotherapy*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Remission Induction
Raport
Tytuł :
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
Autorzy :
Ball BJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
Hsu M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Devlin SM; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Arcila M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Roshal M; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Zhang Y; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Famulare CA; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Goldberg AD; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Cai SF; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Dunbar A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Epstein-Peterson Z; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Menghrajani KN; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Glass JL; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Taylor J; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Viny AD; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Giralt SS; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Gyurkocza B; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Shaffer BC; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Tamari R; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Levine RL; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Tallman MS; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Stein EM; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 May 01; Vol. 96 (5), pp. E171-E175. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural
MeSH Terms :
Gain of Function Mutation*
Genes, ras*
Induction Chemotherapy*
Mutation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Alleles ; Bone Marrow/pathology ; Clone Cells ; High-Throughput Nucleotide Sequencing ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/genetics ; Middle Aged ; Prognosis ; Progression-Free Survival ; Proto-Oncogene Proteins p21(ras)/genetics ; Recurrence ; Remission Induction ; Signal Transduction/genetics
Raport
Tytuł :
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Autorzy :
Matsushima S; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Kobayashi R; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Sano H; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Hori D; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Yanagi M; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Kodama K; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Suzuki D; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Kobayashi K; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Feb; Vol. 68 (2), pp. e28763. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antineoplastic Agents/*adverse effects
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Immunosuppression/*adverse effects
Induction Chemotherapy/*adverse effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Adolescent ; Antineoplastic Agents/therapeutic use ; Asparaginase/adverse effects ; Asparaginase/therapeutic use ; Bacteremia/microbiology ; Child ; Child, Preschool ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Daunorubicin/adverse effects ; Daunorubicin/therapeutic use ; Female ; Humans ; Induction Chemotherapy/methods ; Infant ; Injections, Spinal ; Male ; Neutropenia/microbiology ; Prednisolone/adverse effects ; Prednisolone/therapeutic use ; Remission Induction ; Retrospective Studies ; Vincristine/adverse effects ; Vincristine/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease.
Autorzy :
Hart L; Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McMaster Children's Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Farbod Y; Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McMaster Children's Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Szamosi JC; Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Yamamoto M; Department of Chemistry and Chemical Biology, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Britz-McKibbin P; Department of Chemistry and Chemical Biology, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Halgren C; Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McMaster Children's Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Zachos M; Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McMaster Children's Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Pai N; Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McMaster Children's Hospital, McMaster University, Hamilton, ON L8N 3Z5, Canada.; Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2020 Jun 05; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 05.
Typ publikacji :
Journal Article
MeSH Terms :
Enteral Nutrition*
Gastrointestinal Microbiome*
Induction Chemotherapy*
Adrenal Cortex Hormones/*administration & dosage
Colitis, Ulcerative/*microbiology
Colitis, Ulcerative/*therapy
Crohn Disease/*microbiology
Crohn Disease/*therapy
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Longitudinal Studies ; Male ; Prospective Studies ; Remission Induction ; Treatment Outcome
SCR Disease Name :
Pediatric Crohn's disease
Czasopismo naukowe
Tytuł :
Intravoxel Incoherent Motion Magnetic Resonance Imaging for Prediction of Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma: Comparison With Model-Free Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Autorzy :
Guo B; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Ouyang F; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Ouyang L; Department of Ultrasound, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Huang X; Department of Clinical Laboratory, The Affiliated Shunde Hospital of Guangzhou, Medical University, Foshan, China.
Guo T; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Lin S; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Liu Z; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Zhang R; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Yang SM; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Chen H; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Hu QG; Department of Radiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, China.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jul; Vol. 54 (1), pp. 91-100. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma*
Induction Chemotherapy*
Contrast Media ; Diffusion Magnetic Resonance Imaging ; Humans ; Magnetic Resonance Imaging ; Motion ; Prospective Studies ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Editorial for "Intra-voxel incoherent motion (IVIM) MRI for prediction of induction chemotherapy response in locally advanced hypopharyngeal carcinoma: comparison with model-free dynamic contrast-enhanced MRI".
Autorzy :
Fujima N; Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jul; Vol. 54 (1), pp. 101-102. Date of Electronic Publication: 2021 Mar 28.
Typ publikacji :
Editorial
MeSH Terms :
Carcinoma*
Induction Chemotherapy*
Contrast Media ; Diffusion Magnetic Resonance Imaging ; Humans ; Magnetic Resonance Imaging ; Motion
Opinia redakcyjna
Tytuł :
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction.
Autorzy :
Haydu JE; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Flamand Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Vedula RS; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Versluis J; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Charles A; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Copson KM; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Stone RM; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
DeAngelo DJ; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Lindsley RC; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Luskin MR; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Jul 01; Vol. 96 (7), pp. E259-E262. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Induction Chemotherapy*
Anthracyclines/*therapeutic use
Antineoplastic Agents/*therapeutic use
Cytarabine/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Adult ; Aged ; Anthracyclines/administration & dosage ; Antineoplastic Agents/administration & dosage ; Cytarabine/administration & dosage ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Middle Aged ; Prognosis ; Treatment Outcome
Raport
Tytuł :
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial.
Autorzy :
Liu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Luo L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
Zhao L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhu Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liu H; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Cai L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hu Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Qiu B; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Shen J; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.; Department of Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liu M; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China. .; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. .
Xi M; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China. .; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jun 29; Vol. 12 (1), pp. 4014. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Chemoradiotherapy/*adverse effects
Esophageal Neoplasms/*therapy
Esophageal Squamous Cell Carcinoma/*therapy
Induction Chemotherapy/*adverse effects
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemoradiotherapy/methods ; Cisplatin/therapeutic use ; Disease-Free Survival ; Docetaxel/therapeutic use ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma/pathology ; Female ; Humans ; Induction Chemotherapy/methods ; Male ; Middle Aged ; Prospective Studies ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Single-cell RNA sequencing identifies molecular targets associated with poor in vitro maturation performance of oocytes collected from ovarian stimulation.
Autorzy :
Lee AWT; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Ng JKW; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Liao J; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Luk AC; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Suen AHC; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Chan TTH; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Cheung MY; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Chu HT; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Tang NLS; Department of Chemical Pathology, and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Zhao MP; Assisted Reproductive Technology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Lian Q; Department of Medicine, The University of Hong Kong, Hong Kong SAR, PR China.
Chan WY; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Chan DYL; Assisted Reproductive Technology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Leung TY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, PR China.
Chow KL; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, PR China.; Division of Life Science, Hong Kong University of Science and Technology, Shatin, N.T., Hong Kong SAR, PR China.
Wang W; Department of Obstetrics and Gynecology, IVF Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Wang LH; Institute of Molecular and Cellular Biology & Department of Medical Sciences, National Tsing Hua University, Hsinchu, Taiwan.
Chen NCH; Department of Infertility and Reproductive Medicine, Taiwan IVF Group Center, Hsinchu City, Taiwan.
Yang WJ; Department of Infertility and Reproductive Medicine, Taiwan IVF Group Center, Hsinchu City, Taiwan.
Huang JY; Department of Infertility and Reproductive Medicine, Taiwan IVF Group Center, Hsinchu City, Taiwan.
Li TC; Assisted Reproductive Technology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Lee TL; Developmental and Regenerative Biology Program, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, PR China.
Pokaż więcej
Źródło :
Human reproduction (Oxford, England) [Hum Reprod] 2021 Jun 18; Vol. 36 (7), pp. 1907-1921.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Oocytes*
Ovulation Induction*
Animals ; Cumulus Cells ; Female ; In Vitro Oocyte Maturation Techniques ; Mice ; Oogenesis ; Sequence Analysis, RNA
Czasopismo naukowe
Tytuł :
Induction Therapy or Upfront Surgery? The Debate Rages On: Reply.
Autorzy :
Rhodin KE; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710. Electronic address: .
Raman V; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710.
D'Amico TA; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2021 Jun; Vol. 111 (6), pp. 2085-2086. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :
Letter; Comment
MeSH Terms :
Induction Chemotherapy*
Neoadjuvant Therapy*
Combined Modality Therapy ; Humans
Opinia redakcyjna
Tytuł :
PiggyBac -Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report.
Autorzy :
Li C; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Sun Y; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Wang J; Radiology Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tang L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Jiang H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Guo T; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Liu L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Ai L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xia L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu J; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Lin Z; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Qian Q; Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 May 25; Vol. 12, pp. 599493. Date of Electronic Publication: 2021 May 25 (Print Publication: 2021).
Typ publikacji :
Case Reports; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy, Adoptive*
Remission Induction*
Lenalidomide/*administration & dosage
Lymphoma, Large B-Cell, Diffuse/*therapy
Humans ; Lymphoma, Large B-Cell, Diffuse/immunology ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Recurrence
Czasopismo naukowe
Tytuł :
The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
Autorzy :
Polyzos NP; Department of Obstetrics, Gynecology and Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain.; Faculty of Medicine and Health Sciences, Ghent University (UZ Gent), Gent, Belgium.
Neves AR; Department of Obstetrics, Gynecology and Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain.; Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Drakopoulos P; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
Spits C; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
Alvaro Mercadal B; Hospital de la Santa Creu i Sant Pau, Gynecology Department, Barcelona, Spain.; Fundació Puigvert, Reproductive Medicine Department, Barcelona, Spain.
Garcia S; Department of Obstetrics, Gynecology and Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain.
Ma PQM; IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam.
Le LH; IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam.
Ho MT; IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam.
Mertens J; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
Stoop D; Faculty of Medicine and Health Sciences, Ghent University (UZ Gent), Gent, Belgium.
Tournaye H; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Obstetrics, Gynecology, Perinatology and Reproduction, Institute of Professional Education, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Vuong NL; University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Pokaż więcej
Źródło :
Human reproduction (Oxford, England) [Hum Reprod] 2021 May 17; Vol. 36 (6), pp. 1711-1721.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Ovulation Induction*
Adult ; Asia ; Belgium ; Europe ; Female ; Humans ; Prospective Studies ; Spain ; Vietnam
Czasopismo naukowe
Tytuł :
Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis.
Autorzy :
Okamoto M; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Kitamura M; Department of Nephrology, Nagasaki University Hospital, Nagasaki.
Sato S; Clinical Research Center, Nagasaki University Hospital, Nagasaki.
Fujikawa K; Department of Rheumatology, JCHO Isahaya General Hospital, Isahaya.
Horai Y; Department of Rheumatology, Clinical Research Center, NHO Nagasaki Medical Center, Omura.
Matsuoka N; Nagasaki Medical Hospital of Rheumatology, Nagasaki.
Tsuboi M; Nagasaki Medical Hospital of Rheumatology, Nagasaki.
Nonaka F; Department of Island and Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Shimizu T; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Koga T; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Kawashiri SY; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Iwamoto N; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Tamai M; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Nakamura H; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Origuchi T; Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nishino T; Department of Nephrology, Nagasaki University Hospital, Nagasaki.
Kawakami A; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 May 14; Vol. 60 (5), pp. 2333-2341.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Induction Chemotherapy*
Glomerulonephritis, Membranous/*drug therapy
Immunosuppressive Agents/*therapeutic use
Lupus Nephritis/*drug therapy
Adult ; Female ; Humans ; Japan ; Male ; Middle Aged ; Prognosis ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Comparison of the Long-Acting GnRH Agonist Follicular Protocol with the GnRH Antagonist Protocol in Women Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis.
Autorzy :
Yang R; Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China.
Guan Y; Center for Reproductive Medicine, The Third Affiliated Hospital of Zhengzhou University, Henan Maternal and Children Health Hospital, Zhengzhou, Henan, China.
Perrot V; Ipsen Pharma, Boulogne-Billancourt, France.
Ma J; Ipsen (Beijing) Pharmaceutical Science and Technology Development Co., Ltd, Beijing, China.
Li R; Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China. .
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2021 May; Vol. 38 (5), pp. 2027-2037. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Ovarian Hyperstimulation Syndrome*
Ovulation Induction*
Female ; Fertilization in Vitro ; Gonadotropin-Releasing Hormone ; Humans ; Meta-Analysis as Topic ; Pregnancy ; Sperm Injections, Intracytoplasmic ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł :
IVF Outcomes of Microdose Flare-up, GnRH Antagonist, and Long Protocols in Patients having a Poor Ovarian Response in the First Treatment Cycle.
Autorzy :
Demirdağ E; Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Emniyet Mahallesi, Gazeteci Yazar Muammer Yaşar Bostancı Sokak, 06560 Yenimahalle/Ankara, Turkey.
Akdulum MFC; Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Emniyet Mahallesi, Gazeteci Yazar Muammer Yaşar Bostancı Sokak, 06560 Yenimahalle/Ankara, Turkey.
Guler I; Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Emniyet Mahallesi, Gazeteci Yazar Muammer Yaşar Bostancı Sokak, 06560 Yenimahalle/Ankara, Turkey.
Oguz Y; Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Turkey.
Erdem A; Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Emniyet Mahallesi, Gazeteci Yazar Muammer Yaşar Bostancı Sokak, 06560 Yenimahalle/Ankara, Turkey.
Erdem M; Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine, Emniyet Mahallesi, Gazeteci Yazar Muammer Yaşar Bostancı Sokak, 06560 Yenimahalle/Ankara, Turkey.
Pokaż więcej
Źródło :
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2021 May; Vol. 30 (5), pp. 523-527.
Typ publikacji :
Journal Article
MeSH Terms :
Live Birth*
Ovulation Induction*
Female ; Fertilization in Vitro ; Gonadotropin-Releasing Hormone ; Hormone Antagonists ; Humans ; Observational Studies as Topic ; Pregnancy ; Pregnancy Rate
Czasopismo naukowe
Tytuł :
Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple.
Autorzy :
Schütz NP; Hospital Italiano de Buenos Aires - Servicio de Clínica Médica (Sección Hematología), Buenos Aires, Argentina.
Ochoa P; Instituto Alexander Fleming - Departamento de Hematología, Buenos Aires, Argentina.
Duarte P; CEMIC - Sección Hematología, Buenos Aires, Argentina.
Remaggi G; FUNDALEU - Departamento de Trasplante de Médula ósea, Buenos Aires, Argentina.
Yantorno S; Hospital Italiano de La Plata - Servicio de Hematología (Unidad de Trasplante de Médula ósea), Buenos Aires, Argentina.
Corzo A; Hospital de Clínicas 'José de San Martín' - Departamento de Clínica Médica (División Hematología), Buenos Aires, Argentina.
Zabaljauregui S; Academia Nacional de Medicina - Departamento de Hemato-Oncología (División Oncohematología), Buenos Aires, Argentina.
Shanley C; Hospital Británico - Departamento de Hematología (Unidad de Trasplante de Médula ósea), Buenos Aires, Argentina.
Lopresti S; Hospital Posadas - Departamento de Medicina Interna, Morón, Argentina.
Orlando S; Hospital Rodolfo Rossi - Departamento de Hematología y Trasplante de Médula ósea, La Plata, Argentina.
Verri V; Instituto de Investigaciones Médicas 'Alfredo Lanari' UBA - Departamento de Hematología, Buenos Aires, Argentina.
Quiroga L; Complejo Médico de la Policía Federal Argentina Churruca Visca - Departamento de Clínica Médica (Sección Hematología), Buenos Aires, Argentina.
García CA; Clínica 25 de Mayo, Mar del Plata, Argentina.
Fernández V; Sanatorio Dr. Julio Méndez - Departamento de Clínica Médica (Sección Hematología), Buenos Aires, Argentina.
Fantl D; Hospital Italiano de Buenos Aires - Servicio de Clínica Médica (Sección Hematología), Buenos Aires, Argentina.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Aug; Vol. 38 (3), pp. 363-371. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Induction Chemotherapy/*mortality
Multiple Myeloma/*mortality
Aged ; Bortezomib/administration & dosage ; Cyclophosphamide/administration & dosage ; Dexamethasone/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiple Myeloma/drug therapy ; Multiple Myeloma/pathology ; Prognosis ; Remission Induction ; Retrospective Studies ; Survival Rate ; Thalidomide/administration & dosage
Czasopismo naukowe
Tytuł :
[Clinical Biological Characteristics and Prognostic Factors of Children with Ph ALL].
Autorzy :
Liu ZY; Department of Hematology, Country Capital Children Hospital of Beijing City, Beijing 102208, China.
Sun Y; Department of Hematology, Country Capital Children Hospital of Beijing City, Beijing 102208, China E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2019 Dec; Vol. 27 (6), pp. 1754-1760.
Typ publikacji :
Journal Article
MeSH Terms :
Induction Chemotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Antineoplastic Combined Chemotherapy Protocols ; Child ; Fusion Proteins, bcr-abl ; Humans ; Prognosis ; Remission Induction ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study.
Autorzy :
Feagan BG; Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, ON, Canada. Electronic address: .
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Danese S; Inflammatory Bowel Diseases Center, Humanitas Clinical and Research Center - IRCCS, Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Wolf DC; Center for Crohn's Disease and Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, GA, USA.
Liu WJ; Celgene Corporation, Summit, NJ, USA.
Hua SY; Celgene Corporation, Summit, NJ, USA.
Minton N; Celgene Corporation, Summit, NJ, USA.
Olson A; Celgene Corporation, Summit, NJ, USA.
D'Haens G; Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Sep; Vol. 5 (9), pp. 819-828. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Crohn Disease/*drug therapy
Indans/*therapeutic use
Induction Chemotherapy/*methods
Oxadiazoles/*therapeutic use
Sphingosine 1 Phosphate Receptor Modulators/*therapeutic use
Abdominal Abscess/chemically induced ; Abdominal Abscess/epidemiology ; Administration, Oral ; Adult ; Aged ; Canada/epidemiology ; Crohn Disease/diagnostic imaging ; Crohn Disease/pathology ; Endoscopy/methods ; Endoscopy/statistics & numerical data ; Female ; Humans ; Hungary/epidemiology ; Indans/administration & dosage ; Indans/adverse effects ; Intention to Treat Analysis/methods ; Male ; Middle Aged ; Oxadiazoles/administration & dosage ; Oxadiazoles/adverse effects ; Patient Reported Outcome Measures ; Poland/epidemiology ; Prospective Studies ; Remission Induction ; Sphingosine 1 Phosphate Receptor Modulators/administration & dosage ; Sphingosine 1 Phosphate Receptor Modulators/adverse effects ; Ukraine/epidemiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Comparison between rocuronium and succinylcholine for rapid sequence induction: A systematic review and network meta-analysis of randomized clinical trials.
Autorzy :
de Carvalho CC; Department of Post-graduation, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil; Department of Surgery, Universidade Federal de Campina Grande, Campina Grande, Brazil. Electronic address: .
da Silva DM; Department of Anesthesiology, Hospital das Clínicas da UFPE, Recife, Brazil.
de Athayde Regueira SLP; Department of Surgery, Universidade Federal de Campina Grande, Campina Grande, Brazil.
de Souza ABS; Department of Surgery, Universidade Federal de Campina Grande, Campina Grande, Brazil.
Rego CO; Department of Surgery, Universidade Federal de Campina Grande, Campina Grande, Brazil.
Ramos IB; Department of Surgery, Universidade Federal de Campina Grande, Campina Grande, Brazil.
Dos Santos Neto JM; Department of Anesthesiology, Hospital das Clínicas da UFPE, Recife, Brazil.
Pokaż więcej
Źródło :
Journal of clinical anesthesia [J Clin Anesth] 2021 Sep; Vol. 72, pp. 110265. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Letter; Systematic Review
MeSH Terms :
Rapid Sequence Induction and Intubation*
Succinylcholine*/adverse effects
Androstanols/adverse effects ; Humans ; Intubation, Intratracheal/adverse effects ; Network Meta-Analysis ; Neuromuscular Depolarizing Agents/adverse effects ; Randomized Controlled Trials as Topic ; Rocuronium
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies